Company Filing History:

7 out of 349

Arch Development Corporation

patents

2 out of 832,891

Other

patents

Years Active: 1995-2007

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7235366 - Methods of identifying agonists and antagonists of opioid receptors (2007-06-26),

2. 6319686 - Nucleic acids encoding kappa opioid receptors (2001-11-20),

3. 6239258 - Human Nkx-2.2 polypeptide-encoding nucleotide sequences (2001-05-29),

4. 6235481 - Polynucleotides encoding calpain 10 (2001-05-22),

5. 6187533 - Mutations in the diabetes susceptibility genes hepatocyte nuclear factor (HNF) 1 alpha (&agr;), HNF1&bgr; and HNF4&agr; (2001-02-13),

6. 6096513 - Polynucleotides encoding KAPPA opiod receptors (2000-08-01),

7. 5723299 - Somatostatin receptors (1998-03-03),

8. 5541060 - Detection of glucokinase-linked early-onset non-insulin-dependent (1996-07-30),

9. 5436155 - Isolated DNA encoding a somatostatin receptor (1995-07-25),

Title: Graeme I Bell - Pioneering Inventor from Chicago

Introduction: Graeme I Bell is a distinguished inventor based in Chicago, Illinois, known for his groundbreaking contributions to various fields.

Latest Patents: Graeme I Bell holds several patents in the areas of technology and healthcare, showcasing his innovative mindset and problem-solving abilities.

Career Highlights: With a career spanning over two decades, Graeme I Bell has consistently pushed the boundaries of innovation, leading to significant advancements in his respective industries.

Collaborations: Throughout his career, Graeme I Bell has collaborated with top researchers, engineers, and scientists, fostering a culture of creativity and excellence in his projects.

Conclusion: Graeme I Bell's passion for innovation and his relentless drive to create have solidified his reputation as a trailblazing inventor in Chicago and beyond.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com